C Rad (CRAD B.ST) Osake Kurssi

C Rad AB is primarily active in the medical technology industry.

The main competitors of C Rad AB in the market include Elekta AB, Varian Medical Systems Inc., and Accuray Incorporated.

C Rad AB is a Swedish medical technology company that specializes in innovative solutions for cancer treatment. Founded in 2004, C Rad AB has a rich history of developing advanced products for radiation therapy. With a strong focus on improving patient care, the company offers cutting-edge solutions like the C-RAD Catalyst system, which enhances accuracy and efficiency in radiotherapy. The company's commitment to research and development has made C Rad AB a trusted name in the field of oncology. With a vision to revolutionize cancer treatment, C Rad AB continues to make significant contributions to the medical industry through its state-of-the-art technologies and solutions.

C Rad AB has achieved several significant milestones since its inception. The company successfully developed innovative medical solutions, focusing on advanced imaging systems for radiation therapy. C Rad AB has gained notable recognition for its cutting-edge technologies and has received various awards for its exceptional contributions to the field. Additionally, the company has achieved significant collaborations with leading medical institutions and established a global presence by expanding its operations into multiple countries. C Rad AB continues to push boundaries, providing state-of-the-art solutions that enhance precision and safety in radiation therapy treatments.

C Rad AB is primarily present in Sweden.

C Rad AB represents values such as innovation, quality, and sustainability. As a company, C Rad AB is committed to delivering cutting-edge technology and solutions in the field of advanced radiation therapy. With a focus on developing and commercializing innovative products, C Rad AB aims to improve cancer treatment outcomes and enhance patient care. The company's corporate philosophy revolves around continuous research and development, collaboration with healthcare professionals, and a customer-centric approach. C Rad AB strives to make a positive impact on society by providing state-of-the-art solutions that contribute to the advancement of cancer care.

Analyytikot asettavat tällä hetkellä C Rad-osakkeelle keskimääräisen tavoitehinnan 44,88 SEK (mediaani: 44,88 SEK), mikä merkitsee +33,6 % viimeisimpään hintaan verrattuna. Konsensus perustuu 5 analyytikkoarvioon.

C Rad Analyytikkojen kursstavoitteet 2026

5 analyytikkoa arvioi tällä hetkellä C Rad-osaketta: 4 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat C Rad-yhtiöltä 463,88 M SEK liikevaihtoa ja 2,28 SEK osakekohtaista tulosta.

C Rad Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla C Rad-osake noteerataan hintaan 3,03 EUR (34,20 SEK).

C Rad-osake (CRAD B.ST) on listattuna 4 pörssissä, muun muassa: London (0R44.L), Frankfurt (24C.F), Stockholm (CRAD B.ST).

The company C Rad AB is a leading provider of digital radiology and medical technology solutions. The company offers a wide range of products and services tailored to the needs of patients, doctors, and hospitals. One of the core divisions of C Rad AB is the development and manufacture of digital radiology systems, including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and digital X-ray systems. These systems are capable of creating precise images of tissues and organs while enabling minimally invasive treatments. C Rad AB aims to improve patient care by focusing on the development of systems that enable precise and fast diagnoses. Another important business area is the development of medical software solutions. C Rad AB has developed a range of tools for digitally capturing, archiving, and analyzing radiological images. These analysis tools allow radiologists to make fast diagnoses and plan effective treatments. The software solutions also include a platform for data exchange and collaboration, making it easier for doctors and clinics to share patient images and data. C Rad AB also operates a number of diagnostic centers that offer a comprehensive range of health services. These centers provide rapid tests, radiology services, laboratory diagnostics, and other medical services. The centers are equipped with state-of-the-art technology and provide fast and accurate diagnoses for patients. Finally, C Rad AB also offers a variety of training and support services for patients and medical professionals. The company operates its own training academy, offering training for radiologists and medical personnel. Additionally, the company provides technical support and maintenance services for its products. Overall, the business model of C Rad AB is focused on offering innovative solutions for radiology and digital medicine. The company has a strong research and development department that is constantly working on new technologies and solutions. By combining top-quality products, services, and training, C Rad AB has strengthened its position as a leading provider of medical technology solutions.

odotettu liikevaihto C Rad on 463,88 M SEK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto C Rad on 77,23 M SEK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

C Rad:n hinta-voitto-suhde (P/E) on tällä hetkellä 14,97. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan C Rad-osakkeen arvostusta.

C Rad:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,49. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii C Rad-osakkeen arvostuskennuslukuna.

C Rad:n Eulpool-laatuscore on 5/10.

C Rad:n ISIN on SE0002016352. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

C Rad:n WKN on A0X93X. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

C Rad:n ticker on CRAD B.ST. Tämä pörssinoteeraus käytetään C Rad-osakkeiden kauppaan pörssissä.